Status:
COMPLETED
PET Scan in Patients With Neurocardiologic Disorders
Lead Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Autonomic Nervous System Diseases
Eligibility:
All Genders
Brief Summary
This study is designed to use PET scans in order to measure activity of the sympathetic nervous system. The sympathetic nervous system is the portion of the nervous system that maintains a normal supp...
Detailed Description
This project applies positron emission tomographic (PET) scanning after administration of 6-\[18F\]fluorodopamine (\[18F\]-6F-DA) to visualize sympathetic innervation and function in patients with neu...
Eligibility Criteria
INCLUSION CRITERIA:
The subjects are adult patients in one of the following diagnostic categories: coronary heart disease or chest pain and normal coronary arteries; myocardial dysfunction or failure; hypertension; or dysautonomia. Groups of appropriately matched healthy volunteers are studied concurrently as controls.
EXCLUSION CRITERIA:
Minors are excluded.
Subjects in whom anatomic factors complicate vascular access are excluded.
Subjects who are not expected clinically to tolerate recumbency during the procedures are excluded.
Pregnant or lactating women are excluded.
Cardiology patients may be tested while off their usual medications. In this situation, the patients will be inpatients on the cardiology ward, managed clinically by staff of the Cardiology Branch, DIR, NHLBI. Hypertensives will be tested afer having discontinued anti-hypertensive medications for up to two weeks.
Patients who must take medications continually in the following categories are excluded: anticoagulants, tricyclic antidepressants, barbiturates, aspirin, acetaminophen.
Patients unable to discontinue nicotine or alcohol temporarily are excluded.
Key Trial Info
Start Date :
July 1 1994
Trial Type :
OBSERVATIONAL
End Date :
August 1 2004
Estimated Enrollment :
335 Patients enrolled
Trial Details
Trial ID
NCT00001418
Start Date
July 1 1994
End Date
August 1 2004
Last Update
March 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Neurological Disorders and Stroke (NINDS)
Bethesda, Maryland, United States, 20892